semaglutide 25 mg weight loss Oral Wegovy approved for obesity management by FDA on December 23, 2025 Formulation: High‑dose oral (25 daily) — previously only available as weekly injections. Indication: Adults with obesity (BMI ≥30) Tirzepatide vs. Semaglutide for Weight

Key Takeaway: Proper hydration is the single most important factor for a safe plasma donation while on semaglutide

Sterile Saline (0.9% Sodium Chloride): Some peptides are sensitive to the pH or the alcohol content of bacteriostatic water

Supports their elimination from the body, reducing their toxicity

Providers who skip consultation or medical history review demonstrate insufficient attention to patient safety and contraindication screening

For liraglutide 3 mg (Saxenda), the SCALE trials documented similar rates, with diarrhoea affecting roughly 20% of treated patients

ab104139, Abcam, Cambridge, UK), and images were obtained using a fluorescence microscope (BX51, Olympus)